Bruker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bruker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BRKR

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI NANO, and Bruker Energy and Supercon Technologies (BEST). 

CEO
Frank H. Laukien
CEOFrank H. Laukien
Employees
11,085
Employees11,085
Headquarters
Billerica, Massachusetts
HeadquartersBillerica, Massachusetts
Founded
1960
Founded1960
Employees
11,085
Employees11,085

BRKR Key Statistics

Market cap
9.22B
Market cap9.22B
Price-Earnings ratio
-86.01
Price-Earnings ratio-86.01
Dividend yield
0.31%
Dividend yield0.31%
Average volume
2.33M
Average volume2.33M
High today
—
High today—
Low today
—
Low today—
Open price
$65.09
Open price$65.09
Volume
0.00
Volume0.00
52 Week high
$66.98
52 Week high$66.98
52 Week low
$32.37
52 Week low$32.37

Stock Snapshot

Bruker(BRKR) stock is priced at $60.50, giving the company a market capitalization of 9.22B. It carries a P/E multiple of -86.01 and pays a dividend yield of 0.31%.

On 2026-10-07, Bruker(BRKR) stock opened at $65.09, reached a high of —, and a low of —.

Bruker(BRKR) shares are trading with a volume of 0, against a daily average of 2.33M.

In the last year, Bruker(BRKR) shares hit a 52-week high of $66.98 and a 52-week low of $32.37.

In the last year, Bruker(BRKR) shares hit a 52-week high of $66.98 and a 52-week low of $32.37.

BRKR News

TipRanks 3h
Bruker price target raised to $70 from $58 at Barclays

Barclays analyst Luke Sergott raised the firm’s price target on Bruker (BRKR) to $70 from $58 and keeps an Overweight rating on the shares. The firm adjusted ta...

TipRanks 1d
Bruker announces seminal bioRxiv preprint

Bruker (BRKR) announced a seminal bioRxiv preprint, describing a draft atlas of the human plasma proteome at isoform, or proteoform, resolution. The study was c...

Simply Wall St 2d
Bruker Unveils New Proteomics Tools, Is The Stock Fully Priced?

Bruker (BRKR) just introduced new mass spectrometry and AI workflows for proteomics and nucleic acid research, and also received a multi system high field NMR o...

Bruker Unveils New Proteomics Tools, Is The Stock Fully Priced?

Analyst ratings

50%

of 14 ratings
Buy
50%
Hold
42.9%
Sell
7.1%

More BRKR News

Zacks 5d
Why Bruker is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different wa...

Why Bruker is a Top Momentum Stock for the Long-Term

People also own

Based on the portfolios of people who own BRKR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.